BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36484959)

  • 1. Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer.
    Liang Y; Chen W; Tang Y; Chen M
    Biochem Genet; 2023 Jun; 61(3):1143-1162. PubMed ID: 36484959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of differentially expressed genes in Type 2 Diabetes using in silico approach.
    Gupta MK; Vadde R
    Comput Biol Chem; 2019 Apr; 79():24-35. PubMed ID: 30708140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Crucial Genes and Key Functions in Type 2 Diabetic Hearts by Bioinformatic Analysis.
    Huang X; Zhang KJ; Jiang JJ; Jiang SY; Lin JB; Lou YJ
    Front Endocrinol (Lausanne); 2022; 13():801260. PubMed ID: 35242109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The key genes underlying pathophysiology association between the type 2-diabetic and colorectal cancer.
    Peng WF; Bai F; Shao K; Shen LS; Li HH; Huang S
    J Cell Physiol; 2018 Nov; 233(11):8551-8557. PubMed ID: 29319171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and analysis of hub genes of hypoxia-immunity in type 2 diabetes mellitus.
    Li J; Yan N; Li X; He S; Yu X
    Front Genet; 2023; 14():1154839. PubMed ID: 37153000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the molecular mechanism underlying the psoriasis and T2D by using microarray data analysis.
    Yang L; Zhang L; Du Q; Gong X; Tian J
    Sci Rep; 2023 Nov; 13(1):19313. PubMed ID: 37935955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of key m5C modification-related genes in type 2 diabetes.
    Song Y; Jiang Y; Shi L; He C; Zhang W; Xu Z; Yang M; Xu Y
    Front Genet; 2022; 13():1015879. PubMed ID: 36276976
    [No Abstract]   [Full Text] [Related]  

  • 8. In silico identification and functional prediction of differentially expressed genes in South Asian populations associated with type 2 diabetes.
    Rabby MG; Rahman MH; Islam MN; Kamal MM; Biswas M; Bonny M; Hasan MM
    PLoS One; 2023; 18(12):e0294399. PubMed ID: 38096208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of molecular biomarker candidates for diagnosis and prognosis of chronic periodontitis by bioinformatics analysis of pooled microarray gene expression datasets in Gene Expression Omnibus (GEO).
    Suzuki A; Horie T; Numabe Y
    BMC Oral Health; 2019 Mar; 19(1):52. PubMed ID: 30922293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
    Liu S; Cai Y; Changyong E; Sheng J; Zhang X
    Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological Diseases.
    Rahman MH; Peng S; Hu X; Chen C; Rahman MR; Uddin S; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32041280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
    Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
    PeerJ; 2022; 10():e13932. PubMed ID: 36157062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
    Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
    Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study.
    Zhong M; Wu Y; Ou W; Huang L; Yang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31088900
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of Metabolism-Related Proteins as Biomarkers of Insulin Resistance and Potential Mechanisms of m
    Li YL; Li L; Liu YH; Hu LK; Yan YX
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
    Wu M; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1030278. PubMed ID: 36339449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.